Trial reportThe Journal of clinical endocrinology and metabolism2015
Is Anti-Müllerian Hormone Associated With Fecundability? Findings From the EAGeR Trial.
Trial report in The Journal of clinical endocrinology and metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00467363 (The Effects of Aspirin in Gestation and Reproduction), which is not on this map. Cited by 30 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Effects of Aspirin in Gestation and Reproduction: A Multi-center, Controlled, Double-blind Randomized Trial.
Who cites it
30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 97 citations in OpenAlex.
- The Value of Anti-Müllerian Hormone in the Prediction of Spontaneous Pregnancy: A Systematic Review and Meta-Analysis.Frontiers in endocrinology · 2021Pooled it
- Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2016Guideline
- A prospective study of physical activity and fecundability in women with a history of pregnancy loss.Human reproduction (Oxford, England) · 2018Trial
- Association of testosterone and antimüllerian hormone with time to pregnancy and pregnancy loss in fecund women attempting pregnancy.Fertility and sterility · 2018Trial
- Trends in Anti-Müllerian Hormone (AMH) Testing for Fertility Assessment in Australian General Practice, 2011-2021: A Retrospective Open Cohort Study.The Australian & New Zealand journal of obstetrics & gynaecology · 2026Article
- Anti-Mullerian Hormone As A Predictor Of Live Birth For Patients With Unexplained Recurrent Pregnancy Loss.JBRA assisted reproduction · 2026Article
- Risk of endometriosis progression in infertile women trying to conceive naturally or using IVF.Human reproduction (Oxford, England) · 2025Review
- Negligible serum anti-Müllerian hormone levels and successfully spontaneous pregnancy three times: a case report.Journal of ovarian research · 2025Article
- Ovarian reserve does not influence natural conception: insights from infertile women.Archives of gynecology and obstetrics · 2024Article
- Periconceptional Counselling in Women with Autoimmune Inflammatory Rheumatic Diseases.Journal of clinical medicine · 2024Review
- Serum Anti-Müllerian Hormone Is an Effective Indicator of Antral Follicle Counts but Not Primordial Follicle Counts.Endocrinology · 2023Article
- Low ovarian reserve and risk of miscarriage in pregnancies derived from assisted reproductive technology.Human reproduction open · 2023Article
- AMH and other markers of ovarian function in patients with Turner syndrome - a single center experience of transition from pediatric to gynecological follow up.Frontiers in endocrinology · 2023Review
- Fertility preservation in women with benign gynaecological conditions.Human reproduction open · 2023Article
- Article
- Preconception leukocyte telomere length and pregnancy outcomes among women with demonstrated fecundity.Human reproduction (Oxford, England) · 2021Article
- Beyond Premature Ovarian Insufficiency: Staging Reproductive Aging in Adolescent and Young Adult Cancer Survivors.The Journal of clinical endocrinology and metabolism · 2021Article
- Sporadic anovulation is not an important determinant of becoming pregnant and time to pregnancy among eumenorrheic women: A simulation study.Paediatric and perinatal epidemiology · 2021Article
- Recalled maternal lifestyle behaviors associated with anti-müllerian hormone of adult female offspring.Reproductive toxicology (Elmsford, N.Y.) · 2020Article
- Fertility preservation strategies in borderline ovarian tumor recurrences: different sides of the same coin.Journal of assisted reproduction and genetics · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 4 institutions in 2 countries.
Funding
Abstract
objectiveThe objective of the study was to evaluate whether anti-Müllerian hormone (AMH) is associated with fecundability among women with proven fecundity and a history of pregnancy loss.
designThis was a prospective cohort study within a multicenter, block-randomized, double-blind, placebo-controlled clinical trial ( clinicaltrials.gov , number NCT00467363).
settingThe study was conducted at four US medical centers (2006-2012).
participantsParticipating women were aged 18-40 years, with a history of one to two pregnancy losses who were actively attempting pregnancy.
main outcome measuresTime to human chorionic gonadotropin detected and clinical pregnancy were assessed using Cox proportional hazard regression models to estimate fecundability odds ratios (fecundability odds ratios with 95% confidence interval [CI]) adjusted for age, race, body mass index, income, low-dose aspirin treatment, parity, number of previous losses, and time since most recent loss. Analyses examined by preconception AMH levels: low (<1.00 ng/mL, n = 124); normal (referent 1.00-3.5 ng/mL, n = 595); and high (>3.5 ng/mL, n = 483).
resultsOf the 1202 women with baseline AMH levels, 82 women with low AMH (66.1%) achieved an human chorionic gonadotropin detected pregnancy, compared with 383 with normal AMH (65.2%) and 315 with high AMH level (65.2%). Low or high AMH levels relative to normal AMH (referent) were not associated with fecundability (low AMH: fecundability odds ratios 1.13, 95% CI 0.85-1.49; high AMH: FOR 1.04, 95% CI 0.87-1.24).
conclusionsLower and higher AMH values were not associated with fecundability in unassisted conceptions in a cohort of fecund women with a history of one or two prior losses. Our data do not support routine AMH testing for preconception counseling in young, fecund women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.